Due to the limited size of the different subgroups that were defined according to anti-CCP/anti-CarP profiles, this potential relationship between anti-ACa-Fib antibodies and initial systemic inflammation needs to be replicated in a larger cohort of very early arthritis prior to drawing robust conclusions. This evidence concerns the gene FBL and arthritic joint disease.